Sali Pharmaceutical (Stock code: 300181.SZ) plans to issue convertible bonds to raise funds of no more than 1.56 billion yuan.

Smart Finance APP News, Zhejiang Hisoar Pharmaceutical (300181.SZ) has announced a plan to issue convertible corporate bonds to unspecified investors. The total amount of funds raised from the issuance of convertible corporate bonds to unspecified investors this time will not exceed 1.556 billion yuan (including the principal). The net proceeds from the fundraising, after deducting issuance expenses, are intended to be used for the following projects: the intelligent traditional Chinese medicine health factory (Phase I), the "Wuling+X" product research and development project, and supplementary working capital.